Home > Insider Trading > Filing (0001209191-23-007310)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1237831	Globus Medical Inc	GMED	Surgical & Medical Instruments & Apparatus (3841)	043744954

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752014	W Keith Pfeil	Valley Forge Business Center 2560 General Armistead Avenue Audubon PA 19403	Svp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2021-08-19	833	$49.65	833	No	4	M	Direct
Class A Common Stock	Disposition	2021-08-19	833	$76.13	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	Disposition	2021-08-19	833	$0.00	833	$49.65
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	Disposition	2021-08-19	0	$0.00	0	$53.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2029-09-03	No	4	M	Direct
24,167		2030-01-22	No	4	M	Direct

Footnotes

The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65.
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
These options were granted on September 3, 2019 and are fully vested.
The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019.
These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.